Crystallography, chemistry and structural disorder in the new high- Tc Bi–Ca–Sr–Cu–O superconductor

Superconductivity in Crystallographically Disordered LaHg6.4

The influence of structural disorder on superconductivity is not yet fully understood. A concurrent examination of crystallographic and physical properties of LaHg_6.4 reveals that this material enters a superconducting state below T_c = 2.4 K while showing crystallographic disorder in one dimension. Lanthanum mercuride, which crystallizes in a new structure type (space group Cmcm, a = 9.779(2) Å, b = 28.891(4) Å, c = 5.0012(8) Å, Z = 8), has remained out of reach for nearly 50 years. In this crystal structure, strong disorder is present in the channels that propagate along the [001] direction. By implementing a combination of cutting-edge synthesis and characterization techniques, we were able to circumvent the complexity associated with the low formation temperature and chemical reactivity of this substance and study the superconductivity of LaHg_6.4 in detail.

Chemistry in Superconductors

Superconductors with exotic physical properties are critical to current and future technology. In this review, we highlight several important superconducting families and focus on their crystal structure, chemical bonding, and superconductivity correlations. We connect superconducting materials with chemical bonding interactions based on their structure-property relationships, elucidating our empirically chemical approaches and other methods used in the discovery of new superconductors. Furthermore, we provide some technical strategies to synthesize superconductors and basic but important characterization for chemists needed when reporting new superconductors. In the end, we share our thoughts on how to make new superconductors and where chemists can work on in the superconductivity field. This review is written using chemical terms, with a focus on providing some chemically intuitive thoughts on superconducting materials design.

Cyclic nucleotide Response Element Binding protein (CREB) activation promotes survival signal in human K562 erythroleukemia cells exposed to ionising radiation/etoposide combined treatment

Anticancer therapy addresses the destruction of tumour cells which try to counteract the effect of drugs and/or ionising radiation. Thus the knowledge of the threshold over which the cells do not resist such agents could help in the setting up of therapy protocols. Since a key role was assigned to Cyclic nucleotide Response Element Binding protein (CREB) multigenic family (which is composed of several nuclear transcription factors involved in c-AMP signalling in cell differentiation, proliferation, apoptosis, survival and adaptive response and in hematopoiesis and acute leukemias), attention was paid to the activation of Erk cascade and of the downstream kinases and transcription factors such as p90RSK and CREB. K562 erythroleukemia cell survival to 1.5 Gy ionising radiation with or without etoposide treatment seemed to involve Erk phosphorylation which, regulating p90 RSK, should activate CREB. In parallel, p38 MAP kinase activity down-modulation, along with low caspase-3 activity, and no modification of Bax and Bcl2 levels, supported such evidence. Thus, endogenous CREB activation, triggering a potent survival signal in K562 cells exposed to 1.5 Gy with or without etoposide, led us to suggest that using specific inhibitors against CREB, such as modified phosphorothionate oligodeoxynucleotides (ODN) corresponding to CREB-1 sequence, anticancer therapy efficacy could be improved.